Epidemiology and Long-term Outcome of Patients With VHD

Epidemiology and Long-term Prognosis of Patients With Valvular Heart Diseases (BIA-WAD Study)

Sponsors

Lead Sponsor: Medical University of Bialystok

Source Medical University of Bialystok
Brief Summary

Valvular heart diseases are significant problem in Polish population. Coexistence of coronary artery disease in patients with VHD increases the risk of death and affects further therapeutic strategy. The aim of the study is analysis the epidemiology and the long-term prognosis among patients with VHD.

Detailed Description

Valvular heart diseases are significant problem in Polish population. Coexistence of coronary artery disease in patients with VHD increases the risk of death and affects further therapeutic strategy. Patients with moderate and severe valvular heart diseases are included into the study. The set of variables subject to interpretation consisted of demographic data, medical history, result of coronary angiography, and type of applied percutaneous and surgical treatment

Overall Status Recruiting
Start Date January 2006
Completion Date January 2025
Primary Completion Date January 2010
Study Type Observational
Primary Outcome
Measure Time Frame
Death 3665 days
Secondary Outcome
Measure Time Frame
MACCE 3665 days
Enrollment 2500
Condition
Intervention

Intervention Type: Procedure

Intervention Name: Innovative medical technologies in invasive cardiology and cardiac surgery

Description: A follow-up study included the analysis of medical documentation of the Cardiosurgery and the Invasive Cardiology Departments to provided information on the duration and type of procedure performed.

Arm Group Label: VHD patients

Eligibility

Sampling Method: Non-Probability Sample

Criteria:

Inclusion Criteria: - Valvular heart disease in moderate and severe stages Exclusion Criteria: - Age < 18 years old

Gender: All

Minimum Age: 18 Years

Maximum Age: N/A

Healthy Volunteers: No

Location
Facility: Status: Contact: Investigator: epartment of Invasive Cardiology, Medical University of Bialystok, The Medical University of Bialystok Clinical Hospital Lukasz Kuzma, MD, PhD 660720610 48 [email protected] Pawel Kralisz, PhD Principal Investigator Lukasz Kuzma, PhD Principal Investigator Krzysztof Struniawski, MD Principal Investigator Slawomir Dobrzycki, PhD Principal Investigator
Location Countries

Poland

Verification Date

September 2020

Responsible Party

Type: Principal Investigator

Investigator Affiliation: Medical University of Bialystok

Investigator Full Name: Lukasz Kuzma

Investigator Title: Principal Investigator,

Keywords
Has Expanded Access No
Condition Browse
Arm Group

Label: VHD patients

Description: Patients with moderate and severe valvular heart diseases

Acronym BIA-WAD
Patient Data No
Study Design Info

Observational Model: Case-Only

Time Perspective: Prospective

Source: ClinicalTrials.gov